Home/Science/Voltaren vs Ketro RX
Product Comparison

Voltaren vs Ketro RX Pain Gel: OTC Diclofenac vs Prescription Ketorolac

A hand holding a jar of Ketro RX Pain Gel against a white wall Targeted Pain Relief. Applied Where It Hurts, Not Swallowed.

Ketro RX Pain Gel uses ketorolac, a prescription NSAID that StatPearls describes as having higher demonstrated potency than most other NSAIDs. Voltaren's active ingredient, diclofenac 1%, is an OTC NSAID. Both are topical, but Ketro RX is compounded per patient under physician oversight while Voltaren is sold at a fixed OTC concentration.

Voltaren (diclofenac 1% gel) became the first topical NSAID approved for over-the-counter sale in the US, in February 2020, and is widely available over the counter. But OTC means fixed strength, limited potency, and a one-size-fits-all formulation. For people whose pain needs more than what you can buy off the shelf, prescription-strength ketorolac offers a fundamentally different level of anti-inflammatory power.

This page compares the two products head-to-head: active ingredients, potency, clinical evidence, cost, and when to choose which. No marketing spin. Just the pharmacology.

Rx

Prescription-strength ketorolac, compounded per patient

1%

Voltaren's fixed OTC diclofenac concentration

8,000+

Participants in Cochrane topical NSAID evidence base

Last updated April 16, 2026

Dermatologist Tested, LegitScript Certified, FDA Registered Facility
Quick Summary

Key Takeaways

  • 1. Both Ketro RX and Voltaren are topical NSAIDs that deliver medication through the skin, but Ketro RX uses prescription-strength ketorolac, traditionally reserved for hospital and emergency department use, while Voltaren is OTC diclofenac at a fixed 1% concentration.
  • 2. Voltaren is OTC, affordable ($15-25), and effective for mild to moderate pain. Ketro RX requires a prescription and starts at $110/month, about $3.67 a day with the physician consultation included, but provides higher potency for pain that OTC can't manage.
  • 3. Topical diclofenac 1% gel produced 5-17x lower systemic exposure than oral diclofenac in healthy volunteers (Kienzler 2010, DOI 10.1177/0091270009336234). In osteoarthritis trials, topical NSAIDs as a class showed no significant difference from placebo for GI events, though they showed more withdrawals for adverse events overall, mostly skin reactions. Lower systemic exposure, not zero.
  • 4. The right choice depends on pain severity: mild/occasional pain may respond well to Voltaren, while moderate-to-severe or chronic inflammatory pain may benefit from prescription-strength ketorolac.

Ready to see if prescription-strength topical ketorolac is right for your pain? Start a free online consultation and a licensed physician will review your case within 24 hours.

"You need such a small amount. This helped my jaw pain like nothing else I've used. I just bought the subscription."

Max B. · Verified RX: Pain Gel review

Head to Head

Voltaren vs Ketro RX: Side-by-Side Comparison

Feature Ketro RX Pain Gel Voltaren (Diclofenac)
Active Ingredient Ketorolac (prescription NSAID) Diclofenac sodium 1%
Strength Prescription-strength, compounded per patient Fixed OTC concentration (1%)
Availability Prescription required (online consultation included) Over-the-counter at any pharmacy
Analgesic Class Prescription-strength NSAID, traditionally reserved for hospital and ED use OTC NSAID, broadly used for mild-to-moderate pain
Anti-inflammatory Action Topical NSAID with comparable anti-inflammatory effect to other topical NSAIDs Topical NSAID at fixed 1% diclofenac
GI Side Effects In osteoarthritis trials, topical NSAIDs as a class showed no significant difference from placebo for GI events (OR 0.96). Ketorolac was not among the drugs pooled In osteoarthritis trials, topical NSAIDs as a class showed no significant difference from placebo for GI events (OR 0.96). Topical diclofenac was among the drugs pooled
Application Apply to affected area as directed by physician Apply up to 4x daily per package directions
Cost From $110/month (online consultation included) ~$15-25 OTC
Origin Originally developed by the same compounding team that works with professional sports organizations, including the Boston Red Sox Novartis / GSK consumer health
Compounding Made per patient by US pharmacy (Precision Compounding) Mass-manufactured, fixed formula
A jar of Ketro RX Pain Gel beside a tipped-over bottle of spilled tablets
Molecule by Molecule

Ketorolac vs Diclofenac: The Two NSAIDs Behind the Products

Ketorolac and diclofenac are both NSAIDs that work by inhibiting COX enzymes. Diclofenac 1% gel is the only OTC topical NSAID available in the US, sold as Voltaren and as store brands. Ketorolac is available by prescription only, in oral, nasal spray, IV and IM forms, and the topical ketorolac in Ketro RX Pain Gel is compounded per patient.

Feature Diclofenac (Voltaren) Ketorolac (Toradol)
Drug class NSAID. Inhibits cyclooxygenase (COX) enzymes NSAID. Inhibits cyclooxygenase (COX) enzymes
Brand names Voltaren in the US, Voltarol in the UK. Store brands and other labels sell the same 1% gel, including Aspercreme Arthritis Pain Toradol, listed by MedlinePlus as a discontinued US brand. Generic ketorolac is still available
US prescription status Both. Diclofenac 1% gel is the only OTC topical NSAID available in the US, and diclofenac topicals also carry prescription labels Prescription only
FDA-approved dose forms Oral tablets, topical gel, topical solution Oral, nasal spray, IV, IM (StatPearls)
What the OTC label covers "Temporary relief of arthritis pain ONLY in the following areas: hand, wrist, elbow (upper body areas) foot, ankle, knee (lower body areas)". The label adds: "Do not use...for strains, sprains, bruises or sports injuries" No OTC form exists
What the prescription label covers Diclofenac sodium topical gel 1%: "relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands" Ketorolac tablets: "short-term (5 days or less) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting"
Duration limit on the label OTC Voltaren: "use up to 21 days unless directed by your doctor" Systemic ketorolac: combined IV, IM and oral use "not to exceed 5 days"
Application frequency OTC label: 4 times per day, on no more than 2 body areas at the same time Set by the prescribing provider
Boxed warning on the prescription label "WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS" Four boxed warnings: gastrointestinal, cardiovascular thrombosis, renal, bleeding
Topical head-to-head trial None published against ketorolac None published against diclofenac

Is Toradol the Same as Voltaren?

No. Toradol is a brand name for ketorolac and Voltaren is a brand name for diclofenac, two different NSAID molecules. MedlinePlus lists Toradol as a discontinued US brand with generic ketorolac still available. A search for Toradol vs Voltaren is a search for ketorolac vs diclofenac.

Two naming details cause most of the confusion. Toradol in the US referred to oral and injectable ketorolac, not to a topical product, so a compounded topical ketorolac like Ketro RX Pain Gel is not "Toradol gel". And outside the US the diclofenac brand changes name: Voltarol is the UK brand for the same active ingredient that is sold as Voltaren in the US.

Which Is Stronger, Ketorolac or Diclofenac?

No topical head-to-head trial has been published. The closest evidence is oral. A double-blind randomized trial of 198 emergency department patients with acute low back pain found no difference in overall clinical improvement at five days between ibuprofen 600 mg, ketorolac 10 mg and diclofenac 50 mg.

Two separate facts get collapsed into one in most versions of this question. The first is regulatory: ketorolac is available in the US by prescription only, while diclofenac 1% gel is sold both over the counter and under prescription labels. The second is potency class: StatPearls describes ketorolac as having "higher demonstrated potency than most other NSAIDs", and its US tablet label is written for pain "that requires analgesia at the opioid level". We state both, and we do not present the second as the reason for the first.

On dose equivalence, in one oral-route trial in cancer pain (Pannuti 1999), oral ketorolac 10 mg and oral diclofenac 50 mg produced comparable relief. That is an oral study; no topical equivalence data exists.

Is There a Prescription Version of Voltaren?

Yes. Diclofenac 1% gel also carries a prescription label, indicated for "relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands". Pennsaid is a prescription diclofenac topical solution indicated for the pain of osteoarthritis of the knee.

The two labels are scoped differently. The OTC Voltaren Arthritis Pain label names six joints, allows four applications a day on no more than two body areas at a time, and says to use it up to 21 days unless a doctor directs otherwise. The prescription diclofenac gel label sets a ceiling of 8 g a day on any one upper-extremity joint, 16 g on any one lower-extremity joint, and 32 g a day across all affected joints, with no 21-day self-treatment limit. Same molecule, same 1% strength, different amount of clinical supervision attached.

Being Precise About Our Own Product

There is no published trial comparing topical ketorolac with topical diclofenac, and Ketro RX Pain Gel has not been tested against Voltaren. Compounded medications are not reviewed by the FDA for effectiveness. What can be said is narrower: the two molecules work through the same COX-inhibition mechanism, ketorolac is available in the US by prescription only, and a compounded gel is prepared per patient rather than at one fixed OTC concentration. A licensed provider can advise where each option fits. Start an online consultation if you want one to review your case.

The Pharmacology

Prescription Status and Potency Class, Side by Side

Both ketorolac and diclofenac are non-steroidal anti-inflammatory drugs (NSAIDs). They work through the same basic mechanism: inhibiting cyclooxygenase (COX) enzymes to reduce prostaglandin production, which decreases inflammation, pain, and swelling at the tissue level. Mayo Clinic notes that topical NSAIDs can work as well as oral NSAIDs for many people, with fewer systemic side effects. But the similarity between these two specific molecules ends there.

StatPearls describes ketorolac as having "higher demonstrated potency than most other NSAIDs". Its US tablet label is written for the short-term management of "moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting", with combined use capped at 5 days. That systemic label describes oral and injectable ketorolac, not a compounded topical. In one oral-route trial in cancer pain (Pannuti 1999), oral ketorolac 10 mg and oral diclofenac 50 mg produced comparable relief. That is an oral study; no topical equivalence data exists.

Rx

Ketorolac is available in the US by prescription only. Diclofenac 1% gel is the only OTC topical NSAID available in the US. Voltaren sells it, and so do store brands and other labels, including Aspercreme Arthritis Pain (the same molecule at the same strength).

Diclofenac became the first OTC topical NSAID in the US when Voltaren Arthritis Pain was approved for over-the-counter sale in 2020. At 1% concentration, it provides effective relief for mild to moderate musculoskeletal pain. But 1% diclofenac is a fixed, standardized dose designed to be safe for unsupervised consumer use, not to maximize therapeutic potency. That label also limits where it can go: the hand, wrist, elbow, foot, ankle and knee only, which is why bursitis in the hip or shoulder falls outside it.

Compounded topical ketorolac works differently on the supply side rather than the pharmacology side. It is prepared per patient by a compounding pharmacy on a prescriber's order, not mass-produced at one fixed concentration, and the prescriber sets the strength and the dosing. A licensed provider can advise where each option fits: start an online consultation to have one review your case. For a full competitive breakdown, see our roundup of the best Voltaren alternatives compared.

A woman cradling her elbow with the opposite hand
How They Compare

Prescription Ketorolac vs OTC Diclofenac

Both products deliver NSAID medication through the skin. The difference is potency, formulation control, and physician oversight. Here is how prescription-strength topical ketorolac compares to OTC diclofenac 1% on the metrics that matter.

Ketro RX (Ketorolac)

Prescription-strength topical NSAID, compounded per patient by a US pharmacy under physician supervision.

  • Prescription-only ketorolac, traditionally reserved for hospital and ED use
  • Compounded for site-specific relief
  • Compounded per patient (not mass-produced)
  • Physician-supervised dosing
  • Originally developed by a compounding team that works with professional sports organizations
  • Class-level: topical NSAIDs have lower systemic exposure than the same drug taken by mouth

Voltaren (Diclofenac 1%)

OTC topical NSAID at fixed 1% concentration. Available at any pharmacy without a prescription.

  • Fixed 1% concentration (no customization)
  • Baseline NSAID potency
  • Mass-manufactured formula
  • No physician oversight required
  • Available at any pharmacy or drugstore
  • Class-level: topical NSAIDs have lower systemic exposure than the same drug taken by mouth
The Evidence

What the Topical NSAID Evidence Actually Shows

Published, peer-reviewed data on topical NSAID efficacy, ketorolac potency, and the safety profile of topical vs oral delivery. No marketing claims. Just the research.

An older man in hiking boots gripping his knee

NNT 3.7

Topical Diclofenac, Acute Musculoskeletal Pain

In a Cochrane review subgroup of two studies (314 participants) testing diclofenac Emulgel for acute musculoskeletal pain, the number needed to treat was 1.8. Across all topical diclofenac formulations in that review it was 3.7. These are diclofenac figures, not ketorolac.

Cochrane, Topical NSAIDs for Acute Musculoskeletal Pain

5-17x

Lower Systemic Absorption

Topical NSAIDs produce 5-17x lower peak serum concentrations than oral equivalents. Medication stays where you apply it.

Kienzler et al., J Clin Pharmacol 2010

= Placebo

GI Side Effects (Topical)

Systematic review and meta-analysis: topical NSAIDs showed no significant difference in GI adverse events vs placebo (OR 0.96, 95% CI 0.73-1.27).

Honvo et al., Drugs & Aging 2019

Ketorolac Potency, Pharmacological Comparison

In one oral-route trial in cancer pain (Pannuti 1999), oral ketorolac 10 mg and oral diclofenac 50 mg produced comparable relief. That is an oral study; no topical equivalence data exists. Separately, StatPearls describes ketorolac as having "higher demonstrated potency than most other NSAIDs" and lists its FDA-approved dose forms as oral, nasal spray, IV and IM. Both statements describe systemic ketorolac.

Pannuti et al., Tumori 1999 (PMID 10363074) and Ketorolac, StatPearls

Topical Ketorolac Gel for Acute Pain: Double-Blind RCT

A 1990 double-blind study compared topical ketorolac 2% gel against placebo and against etofenamate in acute ankle sprain. Of 37 patients admitted, 13 received ketorolac. Ankle volume and visual analogue pain scores fell more in the ketorolac group than in the controls, with statistically significant differences on days 4 and 8. It is a small, single, 35-year-old trial of a 2% gel, not a study of any current product.

PubMed PMID 2105985

Cochrane Review: Topical NSAIDs for Acute Musculoskeletal Pain

The Cochrane Collaboration's systematic review of topical NSAIDs for acute musculoskeletal pain analyzed 61 studies with over 8,000 participants, in sprains, strains, contusions and overuse injuries. In a Cochrane review subgroup of two studies (314 participants) testing diclofenac Emulgel for acute musculoskeletal pain, the number needed to treat was 1.8. Across all topical diclofenac formulations in that review it was 3.7. These are diclofenac figures, not ketorolac. Ketoprofen gel reached 2.5 across 5 studies and 348 participants. Ketorolac appears in the review only as one of the topical NSAIDs studied, with no separate result reported.

Cochrane, Topical NSAIDs for Acute Musculoskeletal Pain, PMC6426435

Topical vs Oral NSAIDs: Safety and Efficacy Meta-Analysis

A 2024 meta-analysis published in PMC compared topical vs oral NSAIDs across multiple pain conditions. Topical NSAIDs demonstrated equivalent efficacy to oral for superficial musculoskeletal conditions while producing significantly fewer systemic adverse events. Topical delivery resulted in 2-8% of the peak serum concentration of oral administration, confirming the localized action mechanism.

PMC10980447, Topical vs Oral NSAID Safety and Efficacy

Peer-Reviewed Evidence Cochrane Systematic Review Double-Blind RCT Data LegitScript Certified
Label by Label

What Each Label Covers

Not every pain needs a prescription. The Mayo Clinic's diclofenac guide is a good starting point for understanding what OTC topical NSAIDs can do. Here is an honest framework for when that may be sufficient and when prescription ketorolac makes a meaningful difference. Where you apply it matters as well: the OTC label lists six body areas, and using an anti-inflammatory gel on the neck falls outside them.

A woman holding one hand and wrist in the other

What the OTC Voltaren Label Covers

OTC diclofenac 1% is labeled for the temporary relief of arthritis pain in six named joints. The label says the product is not for strains, sprains, bruises or sports injuries, and has not been shown to work for those.

  • Arthritis pain in the hand, wrist or elbow
  • Arthritis pain in the foot, ankle or knee
  • Mild joint stiffness with low inflammation
  • Intermittent pain that resolves within a few days
  • Preference for no-prescription, immediate access
  • Budget is a primary consideration

What People Raise With a Prescriber

Compounded topical ketorolac is a prescription NSAID prepared per patient rather than at one fixed OTC concentration. Start a free consultation and a licensed provider can advise where each option fits.

  • Moderate-to-severe pain not adequately controlled by OTC
  • Chronic inflammatory conditions (arthritis, TMJ, tendinitis)
  • Situations a licensed provider judges suit a compounded prescription topical
  • Pain that keeps coming back despite OTC treatment
  • Patients who want to avoid oral NSAIDs entirely
  • Post-surgical recovery requiring stronger intervention
  • Professional athletes and high-performance demands

The Short Version

Voltaren made topical NSAID therapy mainstream. Its OTC label covers arthritis pain in six named joints, four times a day, on no more than two body areas, for up to 21 days without a doctor's direction. Compounded topical ketorolac is a prescription NSAID with no OTC form, prepared per patient. No trial has compared the two, so this page compares labels and access rather than outcomes, and a licensed provider can advise where each option fits.

A jar of Ketro RX Pain Gel on a bedside table beside a lamp and a phone
The Ketro Approach

Beyond Voltaren: Prescription and Daily Pain Relief Options

Prescription-strength anti-inflammatory for pain and flares. Daily topical magnesium for ongoing muscle tension and recovery. Both applied directly where you need them, not through your whole body first. For the full landscape of topical options and mechanisms, read our complete guide to topical pain relief.

Ketro RX Pain Gel jar, three-quarter view

Prescription Strength

RX Pain Gel

Compounded topical ketorolac, a prescription NSAID whose systemic forms are used in hospital and emergency department settings. Originally developed by the same compounding team that works with professional sports organizations, including the Boston Red Sox. Compounded per patient by Precision Compounding Pharmacy (US). Applied where it hurts rather than taken by mouth. Online consultation included.

  • Ketorolac, a prescription NSAID, compounded per patient
  • Applied where it hurts, for localized action
  • Dispensed only after a licensed physician reviews your case
  • Compounded per order by US pharmacy
  • Online physician consultation included
A hand holding the Ketro CALM Magnesium Cream tube

Daily Maintenance

CALM Magnesium Cream

Skincare-formulated topical magnesium for daily muscle tension, soreness, and recovery. Magnesium plays a direct role in muscle relaxation and contraction. Fast-absorbing, non-greasy, no sting. Formulated like premium skincare, not drugstore. No prescription needed.

  • Premium transdermal magnesium delivery
  • Supports muscle relaxation and recovery
  • Fast-absorbing, non-greasy formula
  • Formulated like skincare, not drugstore
  • No prescription needed
Common Questions

Voltaren vs Ketro RX FAQ

They are two different NSAIDs. Ketro RX Pain Gel is compounded topical ketorolac, available in the US by prescription only. Voltaren's active ingredient is diclofenac 1%. Diclofenac 1% gel is the only OTC topical NSAID available in the US. Voltaren sells it, and so do store brands and other labels, including Aspercreme Arthritis Pain (the same molecule at the same strength). No trial has compared the two products, so the comparison this page makes is on drug class, label scope and access, not on outcome.
Yes. Ketro RX Pain Gel contains prescription-strength ketorolac and requires a prescription. The process is straightforward: complete a brief online questionnaire, a licensed physician reviews your information (usually within 24 hours), and if approved, Precision Compounding Pharmacy compounds and ships your gel directly to your door. Voltaren (diclofenac 1%) is available without a prescription at any pharmacy.
You should not apply two different topical NSAIDs to the same area simultaneously. Both ketorolac and diclofenac inhibit COX enzymes, and layering them increases the risk of local skin irritation and cumulative systemic NSAID exposure. Consult your prescribing physician before combining topical NSAID products. Some patients use Ketro RX on one affected area and Voltaren on a different area, but only under direct medical guidance.
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID). StatPearls describes it as having "higher demonstrated potency than most other NSAIDs" and lists its FDA-approved dose forms as oral, nasal spray, IV and IM. It was developed for injectable and oral use in acute pain settings: hospitals, emergency departments, and post-surgical recovery. Topical NSAIDs as a class produce lower systemic exposure than the same drug taken by mouth, studied most directly with diclofenac (Kienzler 2010). Equivalent published data for compounded topical ketorolac do not exist. Ketro RX Pain Gel uses topical ketorolac compounded per patient by Precision Compounding Pharmacy.
The FDA has not approved an over-the-counter ketorolac product. Its approved dose forms are oral, nasal spray, IV and IM, all prescription. The US tablet label caps combined use at 5 days and carries boxed warnings for gastrointestinal, cardiovascular thrombotic, renal and bleeding risk. Topical NSAIDs as a class produce lower systemic exposure than the same drug taken by mouth, studied most directly with diclofenac (Kienzler 2010), and equivalent published data for compounded topical ketorolac do not exist. Compounded preparations are dispensed on a prescriber's order rather than through the OTC monograph route.
Topical NSAIDs as a class produce lower systemic exposure than the same drug taken by mouth, studied most directly with diclofenac: topical diclofenac 1% gel produced 5-17x lower systemic exposure than oral diclofenac in healthy volunteers (Kienzler 2010). Equivalent published data for compounded topical ketorolac do not exist. In osteoarthritis trials, a meta-analysis of topical NSAIDs found no significant difference from placebo for GI events (OR 0.96, 95% CI 0.73 to 1.27), and also found more withdrawals for adverse events overall (OR 1.49), mostly skin reactions. Ketorolac was not among the drugs pooled. Lower systemic exposure, not zero.
There is no published onset figure for compounded topical ketorolac, so we do not publish one. For comparison, the OTC Voltaren label says its gel may take up to 7 days to work for arthritis pain and is not for immediate relief. Apply Ketro RX as directed by your prescribing physician, and raise it with them if it is not helping.
The OTC Voltaren label covers arthritis pain in six named joints only, and it says not to use the product for strains, sprains, bruises or sports injuries. People raise compounded topical ketorolac with a prescriber for a wider range of sites, including TMJ, arthritis, back pain, neck and shoulder tension, post-surgical pain, and tendinitis including tennis elbow. No head-to-head trial has compared the two, so a licensed provider can advise where each option fits.
No. Toradol is a brand name for ketorolac and Voltaren is a brand name for diclofenac, two different NSAID molecules. MedlinePlus lists Toradol as a discontinued US brand, with generic ketorolac still available. Toradol referred to oral and injectable ketorolac rather than a topical product, so the compounded topical ketorolac in Ketro RX Pain Gel is not Toradol gel.
No topical head-to-head trial has been published. The closest evidence is oral: a double-blind randomized trial of 198 emergency department patients with acute low back pain found no difference in overall clinical improvement at five days between ibuprofen 600 mg, ketorolac 10 mg and diclofenac 50 mg (Irizarry et al., summarized by AAFP). Two separate facts are worth keeping apart: ketorolac is available in the US by prescription only, and StatPearls describes it as having "higher demonstrated potency than most other NSAIDs". We state both without presenting the second as the reason for the first.
Both, depending on the label. Diclofenac 1% gel is the only OTC topical NSAID available in the US. Voltaren sells it, and so do store brands and other labels, including Aspercreme Arthritis Pain, the same molecule at the same strength. That OTC label has covered arthritis pain in the hand, wrist, elbow, foot, ankle and knee since February 2020, for up to 21 days unless a doctor directs otherwise. Diclofenac 1% gel also exists under a prescription label for osteoarthritis of joints amenable to topical treatment, and Pennsaid is a prescription diclofenac topical solution for knee osteoarthritis. Ketorolac, the NSAID in Ketro RX Pain Gel, has no over-the-counter form.
Ketoprofen is the topical NSAID with the next-largest evidence base after diclofenac. In the Cochrane review of topical NSAIDs for acute musculoskeletal pain, ketoprofen gel reached a number needed to treat of 2.5 (2.0 to 3.4) across 5 studies and 348 participants, against 3.7 (3.2 to 4.3) for topical diclofenac across all its formulations. Cochrane noted the ketoprofen studies date from the 1980s with less well defined outcomes. Naproxen in the US is an oral NSAID, sold over the counter and on prescription, and was not one of the drugs in that topical review.
The brand name, not the drug. Voltarol is the UK name and Voltaren is the US name for topical diclofenac. Haleon, which owns the UK brand, describes diclofenac as "the active ingredient in the medicinal range of topical Voltarol products". Product strengths and pack formats differ between markets, so compare the label rather than the brand name.
Three things, none of them an efficacy claim. The active ingredient is ketorolac, a prescription NSAID, rather than an OTC ingredient. Each order is compounded per patient by Precision Compounding Pharmacy in the US rather than mass-manufactured at a fixed concentration, and every order goes through a licensed physician's review first. Originally developed by the same compounding team that works with professional sports organizations, including the Boston Red Sox. Ketro is LegitScript certified. Compounded medications are not reviewed by the FDA for effectiveness, and no trial has compared Ketro RX Pain Gel with any other topical product.
References

Sources and Citations

  1. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database of Systematic Reviews. 2015;(6):CD007402. PMC6426435
  2. Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews. 2016;(4):CD007400. PubMed 27103611
  3. Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. Journal of Clinical Pharmacology. 2010;50(1):50-61. PubMed 19841157
  4. Honvo G, Leclercq V, Geerinck A, et al. Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs & Aging. 2019;36(Suppl 1):45-57. PMC6509095
  5. Mahmoodi AN, Patel P, Kim PY. Ketorolac. StatPearls. StatPearls Publishing; 2024. NCBI Bookshelf, NBK545172
  6. Topical ketorolac tromethamine gel for pain relief in ankle sprains: a double-blind, placebo-controlled study. PubMed. PMID: 2105985. pubmed.ncbi.nlm.nih.gov/2105985
  7. Topical vs Oral NSAID Safety and Efficacy: Systematic Review and Meta-Analysis. PMC. 2024. PMC10980447
  8. Mayo Clinic. Arthritis pain: Treatments absorbed through your skin. mayoclinic.org
  9. Mayo Clinic. Diclofenac (topical application route). mayoclinic.org
  10. Irizarry E, Restivo A, Salama M, et al. A randomized controlled trial of ibuprofen versus ketorolac versus diclofenac for acute, nonradicular low back pain. Academic Emergency Medicine. 2021;28(11):1228-1235. AAFP POEM summary
  11. Pannuti F, Robustelli della Cuna G, Ventaffrida V, Strocchi E, Camaggi CM. A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. Tumori. 1999;85(2):96-100. PubMed 10363074
  12. Voltaren Arthritis Pain (diclofenac sodium topical gel 1%) Drug Facts. DailyMed. dailymed.nlm.nih.gov
  13. Diclofenac sodium topical gel 1%, prescribing information. DailyMed. dailymed.nlm.nih.gov
  14. Ketorolac tromethamine tablets, prescribing information. DailyMed. dailymed.nlm.nih.gov
  15. Ketorolac. MedlinePlus, US National Library of Medicine. medlineplus.gov
An older woman pressing the side of her neck
Prescription Topical Ketorolac

A prescription NSAID, compounded per patient, applied where it hurts. Physician review included.

About the Ketro Team

Ketro is a premium topical pain relief brand. Our RX Pain Gel was originally developed by the same compounding team that works with professional sports organizations, including the Boston Red Sox, and is now compounded per patient by Precision Compounding Pharmacy in the US. This article is researched and maintained by the Ketro content team. We cite peer-reviewed clinical studies and consult our pharmacy partners on every pharmacology claim. If you find a factual error, email team@ketroskin.com.

This content is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any new treatment. Individual results may vary. Ketro RX Pain Gel requires a prescription. Voltaren is a registered trademark of GSK Consumer Healthcare. Ketro is not affiliated with Voltaren or GSK. Clinical data referenced from published peer-reviewed studies.

Ketro RX Pain Gel

Prescription-strength alternative to Voltaren

START CONSULTATION